Kairos Pharma KAPA
NYSE KAPA
$0.59 +0.01 (+1.93%)
As of: Oct 22, 2026 · 10:34 AM EDT

Kairos Pharma (KAPA) Net Income (2023 - 2025)

Updated

Kairos Pharma's Net Income was -$5.45 million in FY2025, compared with -$2.38 million in FY2024.

Analysis

Kairos Pharma (KAPA) Net Income (2023 - 2025) Analysis & Trends

  • Per Business Quant data, Net Income in earlier years was -$2.38 million in FY2024 and -$1.76 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,163.39 Bn 1,131.97 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 634.39 Bn 552.91 Bn 17.26 Bn 5.53 Bn
3 AbbVie 502.68 Bn 475.79 Bn 12.70 Bn 3.62 Bn
4 Merck 377.37 Bn 331.74 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 303.41 Bn 267.40 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 266.55 Bn 240.24 Bn 12.86 Bn 2.51 Bn
7 Amgen 240.56 Bn 195.96 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 193.19 Bn 167.38 Bn 6.22 Bn -10.50 Bn
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn -248.00 Mn
10 Kairos Pharma 10.83 Mn -1.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -1.42 Mn
Mar 31, 2025 -1.26 Mn
Dec 31, 2024 -980,000.00
Sep 30, 2024 -1.05 Mn
Jun 30, 2024 -253,000.00
Mar 31, 2024 -323,000.00
Dec 31, 2023 -1.12 Mn
Sep 30, 2023 -312,000.00
API Access

Kairos Pharma Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income&ticker=KAPA&period=max&api_key=YOUR_API_KEY